Integrative Medicine

2

Review clinical trials related to Integrative Medicine. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine

To learn more about your experience participating in a virtual Meaning-Centered Psychotherapy group.

Participants needed: 72
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Mar 16, 2026Locations: 1
Eligibility criteria

Age 18 or older. [+7]

Children will not be enrolled in this study. [+2]

Status: Recruiting

Feasibility of Integrating Homeopathic Approach in a Comprehensive Cancer Center

Supportive and palliative care play an important role in cancer treatment, and when introduced early can improve quality of life and may even increase median survival rates, as shown in patients with advanced lung cancer. Complementary and integrative medicine (CIM) is a popular supportive approach among oncology patients and is on the rise worldwide. In many countries, homeopathy is being one the CIM methods integrated with a general sense that this treatment is beneficial to the well-being and quality of life (QoL) of cancer patients. In this observational study we will evaluate the feasibility of integrating homeopathic approach in patients attending the complementary and integrative oncology service at the division of oncology in Rambam Health Campus in Haifa, Israel, a major referral comprehensive cancer center. This observational study will evaluate three main ingredients of acceptance: * Obtaining the reasons that patients willing to integrate this supportive approach * Patient acceptance of this supportive approach as well as compliance with the homeopathic approach * Obtaining retrospective subjective information from the patients through validated quality of life questionnaires. (MYCaW, Distress Thermometer, and ESAS-R) Measures which are used routinely in integrative oncology encounters.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Rambam Health Care CampusUpdated: Aug 7, 2025Locations: 1
Eligibility criteria

• 18 years of age or older [+4]

• Inability to understand the intent of the study and follow the instructions [+2]